ArticleBMC cancer2023

Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.

Yuqi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.